scispace - formally typeset
Open AccessJournal ArticleDOI

Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis.

Reads0
Chats0
TLDR
Surprisingly, it is shown that hematopoietic precursors from TRANCE-, RANK-, or TRAF6-null mice can become osteoclasts in vitro when they are stimulated with TNF-α in the presence of cofactors such as TGF-β.
Abstract
Osteoclasts are derived from myeloid lineage cells, and their differentiation is supported by various osteotropic factors, including the tumor necrosis factor (TNF) family member TNF-related activation-induced cytokine (TRANCE). Genetic deletion of TRANCE or its receptor, receptor activator of nuclear factorB (RANK), results in severely osteopetrotic mice with no osteoclasts in their bones. TNF receptor-associated factor (TRAF) 6 is a key signaling adaptor for RANK, and its deficiency leads to similar osteopetrosis. Hence, the current paradigm holds that TRANCE-RANK interaction and subsequent signaling via TRAF6 are essential for the generation of functional osteoclasts. Surprisingly, we show that hematopoietic precursors from TRANCE-, RANK-, or TRAF6-null mice can become osteoclasts in vitro when they are stimulated with TNF- � in the presence of cofactors such as TGF- � . We provide direct evidence against the current paradigm that the TRANCE- RANK-TRAF6 pathway is essential for osteoclast differentiation and suggest the potential existence of alternative routes for osteoclast differentiation.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems

TL;DR: The two systems should be understood to be integrated and operating in the context of the 'osteoimmune' system, a heuristic concept that provides not only a framework for obtaining new insights by basic research, but also a scientific basis for the discovery of novel treatments for diseases related to both systems.
Journal ArticleDOI

Functions of RANKL/RANK/OPG in bone modeling and remodeling.

TL;DR: The current understanding of the role of the RANKL/RANK/OPG system in bone modeling and remodeling is reviewed to show that the relative concentration of RankL and OPG in bone is a major determinant of bone mass and strength.
Journal ArticleDOI

The molecular understanding of osteoclast differentiation.

TL;DR: The RANKL signaling pathway has promise as a strategy for suppressing the excessive osteoclast formation characteristic of a variety of bone diseases and is controlled by an epigenetic mechanism, which has profound implications for the general mechanism of irreversible cell fate determination.
Journal ArticleDOI

Estrogen deficiency and bone loss: an inflammatory tale

TL;DR: The current understanding of the process of estrogen deficiency-mediated bone destruction is presented and some recent findings and hypotheses to explain estrogen action in bone are explored.
Journal ArticleDOI

Osteoclasts: what do they do and how do they do it?

TL;DR: A number of key observations provide insights into the mechanisms by which precursors commit to the osteoclast phenotype and how the mature cell degrades bone.
References
More filters
Journal ArticleDOI

Osteoclast differentiation and activation

TL;DR: Discovery of the RANK signalling pathway in the osteoclast has provided insight into the mechanisms of osteoporosis and activation of bone resorption, and how hormonal signals impact bone structure and mass.
Journal ArticleDOI

Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families.

TL;DR: Osteoblasts/stromal cells can now be replaced with RANKL and M-CSF in dealing with the whole life of osteoclasts, and new ways to treat several metabolic bone diseases caused by abnormal osteoclast recruitment and functions will be established.
Journal ArticleDOI

RANK is essential for osteoclast and lymph node development.

TL;DR: Investigating the physiological role of the TNF receptor (TNFR) family member, RANK, revealed that RANK provides critical signals necessary for lymph node organogenesis and osteoclast differentiation.
Journal ArticleDOI

TRAF6 is a signal transducer for interleukin-1

TL;DR: The identification of a new TRAF family member is reported, designated TRAF6, which indicates that TRAF proteins may function as signal transducers for distinct receptor families and that TRAf6 participates in IL-1 signalling.
Related Papers (5)